Amedisys (AMED) PT Set at $70.00 by Jefferies Group
Jefferies Group set a $70.00 price objective on Amedisys (NASDAQ:AMED) in a report released on Wednesday morning. The brokerage currently has a buy rating on the health services provider’s stock. Jefferies Group also issued estimates for Amedisys’ Q1 2018 earnings at $0.69 EPS, Q2 2018 earnings at $0.77 EPS, Q3 2018 earnings at $0.76 EPS and Q4 2018 earnings at $0.77 EPS.
Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Amedisys from a hold rating to a buy rating and set a $57.00 price objective for the company in a report on Tuesday, February 6th. BidaskClub upgraded shares of Amedisys from a strong sell rating to a sell rating in a research report on Wednesday, February 7th. Mizuho reiterated a buy rating and issued a $65.00 price target (up from $55.00) on shares of Amedisys in a research report on Wednesday, November 8th. William Blair reiterated an outperform rating on shares of Amedisys in a research report on Tuesday, November 21st. Finally, Robert W. Baird boosted their price target on shares of Amedisys from $50.00 to $60.00 and gave the stock a neutral rating in a research report on Friday, November 10th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $62.36.
Shares of Amedisys (NASDAQ:AMED) opened at $58.52 on Wednesday. The firm has a market cap of $1,988.80, a PE ratio of 26.48, a P/E/G ratio of 1.04 and a beta of 0.62. Amedisys has a 1-year low of $45.60 and a 1-year high of $65.91. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.33 and a quick ratio of 1.33.
A number of institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company raised its position in Amedisys by 1.9% in the second quarter. The Manufacturers Life Insurance Company now owns 22,348 shares of the health services provider’s stock worth $1,404,000 after acquiring an additional 410 shares in the last quarter. Systematic Financial Management LP raised its holdings in Amedisys by 3.3% during the 4th quarter. Systematic Financial Management LP now owns 29,850 shares of the health services provider’s stock worth $1,573,000 after buying an additional 945 shares during the period. Teachers Advisors LLC raised its holdings in Amedisys by 1.5% during the 4th quarter. Teachers Advisors LLC now owns 80,867 shares of the health services provider’s stock worth $4,262,000 after buying an additional 1,191 shares during the period. American International Group Inc. raised its holdings in Amedisys by 6.0% during the 3rd quarter. American International Group Inc. now owns 22,560 shares of the health services provider’s stock worth $1,262,000 after buying an additional 1,285 shares during the period. Finally, Swiss National Bank raised its holdings in Amedisys by 3.2% during the 4th quarter. Swiss National Bank now owns 49,000 shares of the health services provider’s stock worth $2,583,000 after buying an additional 1,500 shares during the period. Hedge funds and other institutional investors own 91.81% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Amedisys (AMED) PT Set at $70.00 by Jefferies Group” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/amedisys-amed-pt-set-at-70-00-by-jefferies-group/1906495.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.